KRINSKY GLENN enters LIXTE BIOTECHNOLOGY HOLDINGS, INC. with 1.47M shares across direct and indirect positions
This filing by KRINSKY GLENN establishes the baseline for all future Form 4 insider transaction reports at LIXTE BIOTECHNOLOGY HOLDINGS, INC..
Direct Indirect
Filed: 4/6/2022ACC: 0001493152-22-009302
10% Owner
Since Dec 2021
1.47M
Baseline shares
10% direct
141.66K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
2
Security positions
1.33M indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned141.66K
Common Stock
IndirectShares owned1.33M
Total
141.66K direct·1.33M indirect1.47M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 141.66K | Direct |
| Common Stock | 1.33M | Indirect |
| Total | 1.47M | 141.66K direct·1.33M indirect |
Derivative Holdings0
No derivative holdings reported